| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
343,298 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,897,756 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
12 |
12 |
| Total Shares Sold |
1,129,833 |
1,419,857 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$62,474,611 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
27 |
27 |
76 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mario Ernest |
Director |
– • – |
2020-07-31 |
4 |
A |
$1.72 |
$17,499 |
D/D |
10,174 |
10,174 |
|
- |
|
| Collinson Stuart J |
Director |
– • – |
2020-07-31 |
4 |
A |
$1.72 |
$1,751 |
D/D |
1,018 |
1,018 |
|
- |
|
| Volck Birgitte |
Director |
– • – |
2020-07-31 |
4 |
A |
$1.72 |
$11,500 |
D/D |
6,686 |
6,686 |
|
- |
|
| Mackaness James H |
Chief Financial Officer |
• – – |
2020-06-26 |
4 |
B |
$1.65 |
$9,999 |
D/D |
6,060 |
16,060 |
2.74 |
5% |
|
| Sinclair Andrew |
Director |
– • – |
2020-06-26 |
4 |
B |
$1.65 |
$5,499,995 |
I/I |
3,333,330 |
10,302,602 |
2.1 |
5% |
|
| Abingworth Llp |
10% Owner |
– – • |
2020-06-26 |
4 |
B |
$1.65 |
$5,499,995 |
I/I |
3,333,330 |
10,302,602 |
1.5 |
5% |
|
| Schuler Jack W |
10% Owner |
– – • |
2020-06-26 |
4 |
B |
$1.65 |
$12,500,002 |
I/I |
7,575,759 |
4,157,042 |
1.5 |
5% |
|
| Schuler Jack W |
10% Owner |
– – • |
2020-06-10 |
4 |
B |
$1.97 |
$666,807 |
I/I |
339,083 |
2,071,883 |
1.5 |
-5% |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2020-06-08 |
4 |
S |
$3.40 |
$513,302 |
I/I |
(150,918) |
655,000 |
|
42% |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2020-06-05 |
4 |
S |
$3.34 |
$164,578 |
I/I |
(49,325) |
805,918 |
|
40% |
|
| Harris William G |
Director |
– • – |
2020-04-30 |
4 |
A |
$3.05 |
$9,406 |
D/D |
3,084 |
3,084 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2020-04-30 |
4 |
A |
$3.05 |
$17,501 |
D/D |
5,738 |
5,738 |
|
- |
|
| Volck Birgitte |
Director |
– • – |
2020-04-30 |
4 |
A |
$3.05 |
$9,412 |
D/D |
3,086 |
3,086 |
|
- |
|
| Collinson Stuart J |
Director |
– • – |
2020-04-30 |
4 |
A |
$3.05 |
$10,837 |
D/D |
3,553 |
3,553 |
|
- |
|
| Hirano Patricia C |
See Remarks |
• – – |
2020-01-23 |
4 |
A |
$3.35 |
$390,275 |
D/D |
116,500 |
116,500 |
|
- |
|
| Anish Bhatnagar |
Chief Executive Officer |
• – – |
2020-01-23 |
4 |
A |
$3.35 |
$1,276,350 |
D/D |
381,000 |
381,000 |
|
- |
|
| Mackaness James H |
Chief Financial Officer |
• – – |
2020-01-23 |
4 |
A |
$3.35 |
$33,500 |
D/D |
10,000 |
10,000 |
|
- |
|
| Yen Kristen |
See Remarks |
• – – |
2020-01-23 |
4 |
A |
$3.35 |
$185,925 |
D/D |
55,500 |
55,500 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2020-01-22 |
4 |
A |
$3.35 |
$35,001 |
D/D |
10,448 |
10,448 |
|
- |
|
| Collinson Stuart J |
Director |
– • – |
2020-01-22 |
4 |
A |
$3.35 |
$23,001 |
D/D |
6,866 |
6,866 |
|
- |
|
| Volck Birgitte |
Director |
– • – |
2020-01-22 |
4 |
A |
$3.35 |
$19,520 |
D/D |
5,827 |
5,827 |
|
- |
|
| Harris William G |
Director |
– • – |
2020-01-22 |
4 |
A |
$3.35 |
$18,814 |
D/D |
5,616 |
5,616 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-12-02 |
4 |
S |
$1.62 |
$55,125 |
I/I |
(34,028) |
3,633,805 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-27 |
4 |
S |
$1.53 |
$4,434 |
I/I |
(2,898) |
3,667,833 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-26 |
4 |
S |
$1.55 |
$23,515 |
I/I |
(15,171) |
3,670,731 |
|
- |
|
386 Records found
|
|
Page 8 of 16 |
|
|
